Department of Medicine, University of Perugia, Perugia, Italy.
Research, CSL Behring AG, Bern, Switzerland.
Eur J Immunol. 2019 Jan;49(1):195-198. doi: 10.1002/eji.201847774. Epub 2018 Oct 29.
Intravenous immunoglobuin (IVIG) exerts protective effects in experimental allergic bronchopulmonary aspergillosis (ABPA) via a sialylation-dependent mechanism. The protection was associated with reduced recruitment of eosinophils, diminished goblet cell hyperplasia, suppressed Th2 and Th17 responses and reciprocally enhanced regulatory T cells and IL-10, and decreased IgE levels in the circulation.
静脉注射免疫球蛋白(IVIG)通过唾液酸化依赖的机制在实验性变应性支气管肺曲霉病(ABPA)中发挥保护作用。这种保护作用与嗜酸性粒细胞募集减少、杯状细胞增生减少、Th2 和 Th17 反应受抑制、调节性 T 细胞和 IL-10 增强以及循环中 IgE 水平降低有关。
Expert Rev Clin Immunol. 2017-1
Indian J Chest Dis Allied Sci. 2000
Front Immunol. 2024
Mycopathologia. 2023-10
Brain. 2022-5-24
Exp Suppl. 2021